This trial looks at how hepatic impairment affects how a drug is absorbed and used in the body.
- Liver Disease
4 Primary · 15 Secondary · Reporting Duration: Day 1 before dosing (0 hour) and at multiple time points up to 504 hours post-dose
Awards & Highlights
2 Treatment Groups
Group B: Moderate or Mild Hepatic Impairment
1 of 2
Group A: Normal Hepatic Function
1 of 2
32 Total Participants · 2 Treatment Groups
Primary Treatment: Group B: Moderate or Mild Hepatic Impairment · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 70 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is eligibility for the clinical trial limited to a certain age range?
"This medical research project is open to participants aged 18 and above, up until those who are 70 years of age." - Anonymous Online Contributor
Can you provide insight into the safety of Group A: Normal Hepatic Function for patients?
"In our evaluation, Group A: Normal Hepatic Function received a score of 1 as this is only an initial Phase 1 trial. This means that data confirming safety and efficacy are limited at present." - Anonymous Online Contributor
Can I become involved in this medical experiment?
"In order to be considered for participation in this clinical trial, applicants must have a diagnosed liver condition and are within the 18-70 year old age range. 32 volunteer patients will take part in this research project." - Anonymous Online Contributor
Is participation currently allowed in this research endeavor?
"According to the information located on clinicaltrials.gov, this trial is not actively seeking patients. It was initially posted in March 15th 2023 and most recently updated on 3/1/2023. Despite that, there are still 255 other trials looking for participants right now." - Anonymous Online Contributor